These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15675110

  • 21. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 22. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T, Beyenne J, Feldman B, Adeli K, Silverman E.
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [Abstract] [Full Text] [Related]

  • 23. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW, Misso N, Aggarwal S, Thompson PJ, Walters EH.
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [Abstract] [Full Text] [Related]

  • 24. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C.
    Rheumatology (Oxford); 2003 Jun; 42(6):758-62. PubMed ID: 12730535
    [Abstract] [Full Text] [Related]

  • 26. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A.
    Przegl Lek; 2005 Jun; 62(9):838-42. PubMed ID: 16541713
    [Abstract] [Full Text] [Related]

  • 27. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P, Stein CM.
    J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
    [Abstract] [Full Text] [Related]

  • 28. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A, Pochopień-Kenig G, Scieszka J.
    Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
    [Abstract] [Full Text] [Related]

  • 29. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 30. Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.
    Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB.
    J Rheumatol; 2000 Sep; 27(9):2142-5. PubMed ID: 10990225
    [Abstract] [Full Text] [Related]

  • 31. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA, Malaponte G, Pennisi P, Li Volti G, Trovato G, Mangiafico M, Bevelacqua Y, Mazza F, Fiore CE.
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [Abstract] [Full Text] [Related]

  • 32. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus.
    Wong CK, Lit LC, Tam LS, Li EK, Lam CW.
    Rheumatology (Oxford); 2005 May; 44(5):602-6. PubMed ID: 15705633
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 34. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 35. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Jun; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 36. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ.
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [Abstract] [Full Text] [Related]

  • 37. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
    Chung CP, Oeser A, Solus J, Avalos I, Gebretsadik T, Shintani A, Linton MF, Fazio S, Stein CM.
    J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
    [Abstract] [Full Text] [Related]

  • 38. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ, Woo M, Nam JH, Baek J, Im CH, Lee EY, Lee EB, Park KS, Song YW.
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [Abstract] [Full Text] [Related]

  • 39. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
    Lozovoy MA, Simão AN, Hohmann MS, Simão TN, Barbosa DS, Morimoto HK, Reiche EM, Cecchini R, Dichi I.
    Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A.
    Arthritis Rheum; 2006 Dec 15; 55(6):892-9. PubMed ID: 17139666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.